Ticker
FENCCompany Name
FENNEC PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 44.88M | $ 18.7M | 41.68% |
3/31/2025 | $ 46.4M | $ 22.68M | 48.87% |
12/31/2024 | $ 44.95M | $ 26.63M | 59.26% |
9/30/2024 | $ 58.92M | $ 40.32M | 68.43% |
6/30/2024 | $ 63.16M | $ 43.05M | 68.17% |
3/31/2024 | $ 69.19M | $ 51.18M | 73.97% |
12/31/2023 | $ 26.86M | $ 13.27M | 49.39% |
9/30/2023 | $ 19.03M | $ 12.4M | 65.16% |
6/30/2023 | $ 19.44M | $ 14.96M | 76.96% |
3/31/2023 | $ 21.82M | $ 18.39M | 84.28% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for FENNEC PHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 33.17M ] / Assets [ $ 34.07M ]
(=) Cash to Assets [ 97.35% ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.8% |
average | 9.79% |
median | 6.44% |
std | 9.55% |